Phase II of a clinical trial involving surgery, radiation, and chemotherapy is actively recruiting patients with pleural mesothelioma.
Nick Ursta, an EMT, firefighter, and construction worker, was a victim of pleural mesothelioma, an aggressive form of cancer caused by asbestos exposure.
Each year, members of the medical community, non-profits, and patient organizations join forces to bring lung cancer back into the public eye.
The combination of imaging features with a history of asbestos exposure may be enough information to diagnose pleural mesothelioma.
A non-invasive treatment that combines chemotherapy with electrical currents to shrink mesothelioma tumors appears to be working for a group of patients.
Phase II of a clinical trial is recruiting mesothelioma patients to test the effectiveness of two immunotherapy medications in combination.
Each year on September 26th, the medical community observes Mesothelioma Awareness Day. This year, Mesothelioma Hub remembers Inez St. John.
In August, the Centers for Medicare & Medicaid Services (CMS) approved the use of CAR T-cell therapy in patients with two specific cancers.
Results of a recent Phase 3 clinical trial lead researchers to believe immunotherapy drug Ofev is ineffective. Here are the details.
The latest treatment for mesothelioma patients combines the power of electric currents with platinum-based chemotherapy drugs.